![]() |
市場調查報告書
商品編碼
1930087
全球空膠囊市場:市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的考量、未來預測(2026-2034)Empty Capsules Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
預計2025年全球空膠囊市場規模將達36.7億美元,從2026年的39.1億美元成長至2034年的65.8億美元,預測期內複合年增長率(CAGR)為6.74%。北美地區將引領市場,2025年市場佔有率將達到33.66%,這主要得益於該地區較高的診斷和治療率、對膠囊劑型的強烈偏好以及膳食補充劑消費量的增長。
空膠囊是用來封裝活性藥物成分或非活性物質的外殼。這些膠囊通常使用明膠、羥丙基甲基纖維素(HPMC)、澱粉或普魯蘭多醣等材料製成。 製藥廠商擴大採用膠囊製劑、老齡化社會對膳食補充劑的需求不斷增長,以及膠囊在化妝品和食品行業的應用日益廣泛,這些都是推動市場增長的關鍵因素。
市場概覽及主要亮點
新冠疫情的影響
由於人們為了增強免疫力而增加了維生素和礦物質等營養補充劑的消費,新冠疫情對空膠囊市場產生了積極影響。在此期間,主要市場參與者的收入均有所成長。 例如,Natural Capsules Limited 報告稱,其營收從 2019 財年的 830 萬美元增長至 2020 財年的 1,080 萬美元。疫情過後,市場趨於穩定,製造商正專注於擴大 HPMC 膠囊的生產,以滿足國內外市場的需求。
市場趨勢
液態填充硬膠囊需求成長
一個顯著的市場趨勢是,消費者越來越傾向於選擇液態填充硬膠囊 (LFHC) 而非軟膠囊。軟膠囊具有很強的吸濕性,在水分平衡條件下容易變質。為了克服這些局限性,製造商正在轉向使用硬明膠和 HPMC 膠囊,這些膠囊具有更好的穩定性、更長的保質期和更高的耐溫性。
例如,CapsCanada 於 2022 年 2 月獲得液態填充阿斯匹靈膠囊的批准,並於 2021 年 3 月在北美推出液態填充硬膠囊生產服務。這些趨勢正在顯著推動市場成長。
市場成長驅動因素
擴張策略與新產品發布
隨著人口老化加劇,關節、骨骼、消化和肌肉骨骼疾病的發生率不斷上升,推動了對藥物和營養補充劑的需求。為了應對這一趨勢,製造商正在擴大產能、推出新產品並收購競爭對手。
例如,2022 年 12 月,Vantage Nutrition(ACG 集團)收購了 AquaCap,以增強其生產能力。同樣,Vivion(Operio 集團)於 2023 年 2 月推出了新的明膠、羥丙甲纖維素 (HPMC) 和普魯蘭膠囊,從而擴展了其產品線。
營養補充膠囊需求成長
由於健康意識的提高、預防醫學的普及以及對後疫情時代免疫力的關注,營養補充膠囊的需求正在增長。隨著全球人口越來越依賴膳食補充劑進行長期健康管理,對素食膠囊和羥丙基甲基纖維素(HPMC)膠囊的需求也在上升。
根據行業報告顯示,約77%的美國成年人服用膳食補充劑,而美國和歐洲近50%的膳食補充劑是素食膠囊。這是推動市場成長的主要因素。
市場限制因子
原物料價格上漲
原物料價格上漲,尤其是明膠和羥丙基甲基纖維素(HPMC)的價格上漲,給市場帶來了挑戰。除了製藥、食品和膳食補充劑產業需求的成長外,地緣政治動盪和原油價格上漲也推高了生產成本。 例如,預計2022年印度HPMC價格將達到每噸6,015.6美元,將影響製造商的利潤率。
依類型
截至2024年,由於明膠膠囊在醫藥領域的廣泛應用和較高的生產效率,明膠膠囊將佔市場主導地位。然而,由於HPMC膠囊具有適合素食者、低水分含量、穩定性好以及與飲食習慣相容等優點,因此預計其複合年增長率(CAGR)將最高。
依功能
到2026年,速釋膠囊將以65.98%的市佔率領先,這主要得益於市場對酸劑和抗生素的高需求。由於成本高昂且配方複雜,緩釋膠囊和延遲釋放膠囊的成長速度預計會較為緩慢。
依最終使用者劃分
預計到2026年,製藥公司將佔市場主導地位,市場佔有率高達59.13%,這主要得益於疾病盛行率的上升和政府激勵措施。營養補充劑生產商預計將經歷最快的增長速度,因為消費者對補充劑的需求日益增長。
The global empty capsules market was valued at USD 3.67 billion in 2025 and is projected to grow from USD 3.91 billion in 2026 to USD 6.58 billion by 2034, registering a CAGR of 6.74% during the forecast period. North America dominated the market with a 33.66% share in 2025, supported by high diagnosis and treatment rates, strong preference for capsule-based dosage forms, and rising consumption of dietary supplements.
Empty capsules are shells used to enclose active pharmaceutical ingredients and inert substances. These capsules are commonly manufactured using gelatin, hydroxypropyl methylcellulose (HPMC), starch, or pullulan. The growing adoption of capsule formulations by pharmaceutical manufacturers, increasing nutraceutical demand among the aging population, and expanding use of capsules in cosmeceutical and food industries are key factors driving market growth.
Market Snapshot & Key Highlights
Impact of COVID-19
The COVID-19 pandemic positively influenced the empty capsules market due to increased consumption of dietary supplements such as vitamins and minerals to boost immunity. Major market players witnessed revenue growth during this period. For instance, Natural Capsules Limited reported revenue growth from USD 8.3 million in FY 2019 to USD 10.8 million in FY 2020. Post-pandemic, the market stabilized, with manufacturers focusing on expanding HPMC capsule production for domestic and international markets.
Market Trends
Rising Demand for Liquid-Filled Hard Capsules
A notable trend in the market is the increasing preference for liquid-filled hard capsules (LFHCs) over softgel capsules. Softgel capsules are hygroscopic and prone to degradation during moisture equilibrium. To overcome these limitations, manufacturers are shifting toward hard gelatin and HPMC capsules, which offer better stability, longer shelf life, and resistance to higher temperatures.
For example, in February 2022, CapsCanada received approval for a liquid-filled aspirin capsule, while in March 2021, the company launched a liquid-filled hard capsule manufacturing service in North America. These developments are contributing significantly to market growth.
Market Growth Drivers
Expansion Strategies and New Product Launches
The growing aging population has led to increased prevalence of joint, bone, gastrointestinal, and musculoskeletal disorders, boosting demand for pharmaceutical and nutraceutical products. This trend has encouraged manufacturers to expand production capacities, launch new products, and acquire competitors.
For instance, in December 2022, Vantage Nutrition (ACG Group) acquired AquaCap, strengthening its manufacturing capabilities. Similarly, Vivion (Operio Group) launched new gelatin, HPMC, and pullulan capsules in February 2023, expanding customer offerings.
Rising Demand for Nutraceutical Capsules
Increasing health awareness, preventive healthcare adoption, and post-pandemic immunity concerns have fueled demand for nutraceutical products in capsule form. A large portion of the global population now prefers dietary supplements for long-term health management, boosting demand for vegetarian and HPMC capsules.
According to industry articles, around 77% of American adults consume dietary supplements, and nearly 50% of nutraceutical products in the U.S. and Europe use vegetarian capsules, significantly supporting market growth.
Market Restraint
Rising Raw Material Prices
The market faces challenges due to inflating prices of raw materials, particularly gelatin and HPMC. Increased demand from pharmaceutical, food, and nutraceutical industries, coupled with geopolitical disruptions and high crude oil prices, has raised production costs. For example, HPMC prices in India reached USD 6,015.6 per metric ton in 2022, impacting manufacturers' profit margins.
By Type
The gelatin segment dominated the market in 2024 due to its widespread pharmaceutical use and manufacturing efficiency. However, HPMC capsules are expected to grow at the highest CAGR owing to their vegetarian nature, low moisture content, stability, and compliance with dietary preferences.
By Functionality
The immediate-release segment led the market with 65.98% share in 2026, driven by high demand for antacids and antibiotics. Sustained and delayed-release capsules are expected to grow at a slower pace due to higher costs and formulation complexities.
By End User
Pharmaceutical companies dominated the market with a 59.13% share in 2026, supported by rising disease prevalence and government incentives. Nutraceutical manufacturers are expected to grow at the fastest rate due to increasing consumer preference for dietary supplements.
Competitive Landscape
The market is consolidated, led by companies such as Lonza, ACG, QUALICAPS, CapsCanada, Natural Capsules Limited, and Nectar Lifesciences. Players are focusing on product innovation, geographic expansion, and TiO2-free capsule development to strengthen their market position.
Conclusion
The global empty capsules market, valued at USD 3.67 billion in 2025, grew to USD 3.91 billion in 2026 and is projected to reach USD 6.58 billion by 2034. Market growth is driven by rising pharmaceutical and nutraceutical demand, technological advancements in capsule delivery, and expanding use of vegetarian capsules. Although raw material price volatility remains a challenge, ongoing innovation, strategic expansions, and increasing healthcare awareness are expected to sustain market growth throughout the forecast period.
By Type, Functionality, End User, and Region
Segmentation By Type
By Functionality
By End User
By Region